Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
GLP-1
Insights
Brazil Eyes R$1.5 Billion a Year for GLP-1 Weight-Loss Drugs, Targets Discounts of Up to 90%
September 29, 2026
Insights
JBS’s Tomazoni says “there is no second China” as Brazilian agribusiness enters new cycle
September 10, 2026
Behind the Lines
Brazil’s health plans may be the hidden winners of the GLP-1 boom
August 24, 2026
Insights
JBS Pushes From Commodity Protein Into Nutrition, Eggs and Biotech
June 19, 2026
Insights
Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen
May 26, 2026
Insights
XP Lifts Raia Drogasil to Buy as GLP-1 Drives New Growth Cycle
December 7, 2025
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
